Oxtex Overview
- Year Founded
-
2011
- Status
-
Out of Business
- Employees
-
12
- Latest Deal Type
-
Liquidation
- Investors
-
1
Oxtex General Information
Description
Developer of tissue expanders designed to help in reconstructive and dental surgery. The company's tissue expanders include a range of novel devices and have a number of applications in a range of reconstructive surgical procedures including scar revision, tumor removal, correction of birth defects, and restorative dentistry, thereby enabling surgeons to have better procedures for plastic surgery with the scars lasting for very less time.
Contact Information
Website
www.oxtex.comCorporate Office
- C/O Cork Gully Llp
- 6 Snow Hill
- London EC1A 2AY
- England, United Kingdom
Corporate Office
- C/O Cork Gully Llp
- 6 Snow Hill
- London EC1A 2AY
- England, United Kingdom
Oxtex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Bankruptcy: Liquidation | 01-Oct-2019 | Completed | Out of Business | |||
| 9. Early Stage VC (Series B) | 25-Nov-2018 | Completed | Generating Revenue | |||
| 8. Early Stage VC | 07-Jun-2017 | Completed | Startup | |||
| 7. Early Stage VC (Series A) | 02-Dec-2016 | Completed | Startup | |||
| 6. Early Stage VC | 17-Apr-2013 | Completed | Startup | |||
| 5. Grant | 08-Mar-2013 | Completed | Startup | |||
| 4. Grant | 13-Mar-2012 | Completed | Startup | |||
| 3. Early Stage VC | 07-Mar-2012 | Completed | Startup | |||
| 2. Seed Round | 01-Aug-2011 | $715K | $715K | Completed | Startup | |
| 1. University Spin-Out | 10-May-2011 | Completed | Startup |
Oxtex Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 9,169 | $0.001290 | $11.26 | $11.26 | 1x | $11.26 | 1.32% | |
| Ordinary | 50,634 | $0.001290 | $11.26 | $11.26 | 1x | $11.26 | 7.29% |
Oxtex Patents
Oxtex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201720370-D0 | A nasal device | Active | 06-Dec-2017 | ||
| GB-2569145-A | A nasal device | Active | 06-Dec-2017 | ||
| WO-2019110995-A1 | A nasal device | Inactive | 06-Dec-2017 | ||
| GB-2548920-A | A concertinaed expandable component | Active | 01-Apr-2016 | ||
| GB-2548920-B | A concertinaed expandable component | Inactive | 01-Apr-2016 | A61B90/02 |
Oxtex Signals
Oxtex Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| University of Oxford | University |
Oxtex FAQs
-
When was Oxtex founded?
Oxtex was founded in 2011.
-
Where is Oxtex headquartered?
Oxtex is headquartered in London, United Kingdom.
-
What is the size of Oxtex?
Oxtex has 12 total employees.
-
What industry is Oxtex in?
Oxtex’s primary industry is Surgical Devices.
-
Is Oxtex a private or public company?
Oxtex is a Private company.
-
What is Oxtex’s current revenue?
The current revenue for Oxtex is .
-
How much funding has Oxtex raised over time?
Oxtex has raised $9.1M.
-
Who are Oxtex’s investors?
University of Oxford has invested in Oxtex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process